These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 163139)

  • 1. "Residual" mammary carcinoma following simulated partial mastectomy.
    Rosen PP; Fracchia AA; Urban JA; Schottenfeld D; Robbins GF
    Cancer; 1975 Mar; 35(3):739-47. PubMed ID: 163139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes.
    Veronesi U; Cascinelli N; Greco M; Bufalino R; Morabito A; Galluzzo D; Conti R; De Lellis R; Delle Donne V; Piotti P
    Ann Surg; 1985 Dec; 202(6):702-7. PubMed ID: 3000303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and survival of female patients with nonpalpable breast carcinoma.
    Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
    Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of conservative operations for breast cancer.
    Hermann RE; Esselstyn CB; Crile G; Cooperman AM; Antunez AR; Hoerr SO
    Arch Surg; 1985 Jun; 120(6):746-51. PubMed ID: 2988482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoechoic axillary lymph node metastases of mucinous carcinoma of the breast: a case report.
    Kamitani K; Ono M; Toyoshima S; Mitsuyama S; Anan K; Ikeda Y
    Breast Cancer; 2006; 13(4):382-5. PubMed ID: 17146168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of carcinoma of the breast. I. Pathological finding and pattern of relapse.
    Lee YT; Terry R
    J Surg Oncol; 1983 May; 23(1):11-5. PubMed ID: 6302400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.
    Wang X; Zhao Y; Cao X
    Breast J; 2010; 16(1):32-7. PubMed ID: 20465598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large paraffin sections and chemical clearance of axillary tissues as a routine procedure in the pathological examination of the breast.
    Gibbs NM
    Histopathology; 1982 Sep; 6(5):647-60. PubMed ID: 6292074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are prognostic factors for local control of breast cancer treated by primary radiotherapy significant for patients treated by mastectomy?
    Rosen PP; Kinne DW; Lesser M; Hellman S
    Cancer; 1986 Apr; 57(7):1415-20. PubMed ID: 3004690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy.
    Dawson PJ; Ferguson DJ; Karrison T
    Cancer; 1982 Nov; 50(10):2131-8. PubMed ID: 6290024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraductal carcinoma of the breast.
    von Rueden DG; Wilson RE
    Surg Gynecol Obstet; 1984 Feb; 158(2):105-11. PubMed ID: 6320480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary lymphadenectomy for intraductal carcinoma of the breast.
    Silverstein MJ; Gierson ED; Colburn WJ; Rosser RJ; Waisman JR; Gamagami P
    Surg Gynecol Obstet; 1991 Mar; 172(3):211-4. PubMed ID: 1847243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically occult breast cancer. Multicentricity and implications for treatment.
    Schwartz GF; Patchefsky AS; Feig SA; Shaber GS; Schwartz AB
    Ann Surg; 1980 Jan; 191(1):8-12. PubMed ID: 6243455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastases to the upper levels of the axillary nodes in carcinoma of the breast and its implications for nodal sampling procedures.
    Pigott J; Nichols R; Maddox WA; Balch CM
    Surg Gynecol Obstet; 1984 Mar; 158(3):255-9. PubMed ID: 6701738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The range of removing fatty tissue and lymph nodes by a modified radical mastectomy with preservation of the major and minor pectoral muscles].
    Kanai T
    Nihon Geka Gakkai Zasshi; 1983 Feb; 84(2):103-12. PubMed ID: 6325863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing patterns of breast cancer. Lucy Wortham James lecture (clinical).
    Urban JA
    Cancer; 1976 Jan; 37(1):111-7. PubMed ID: 1247947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.